The business enterprise R&D expenditure in the manufacture of irradiation, electromedical, and electrotherapeutic equipment in Japan shows a decreasing trend. From 2024 to 2028, there's a consistent decline from 785.55 million US dollars PPP (2015) in 2024, reaching 714.04 million by 2028. This represents a negative year-on-year variation, indicating reduced investment in innovation over this period. As of 2023, the expenditure figure was higher, suggesting a shift in budget priorities.
Future trends to watch for include advancements in alternative medical technologies that could drive innovation and investment, regulatory changes impacting R&D priorities, and economic factors influencing funding allocations in Japan's biomedical equipment sector.
